Otc - Purpose
| Active ingredients (in each extended-release bi-layer tablet) | Purposes |
| Dextromethorphan HBr 30 mg | Cough suppressant |
| Guaifenesin 600 mg | Expectorant |
The following Structured Product Label (SPL) was submitted to the FDA by Atlantic Biologicals Corp. for the product Mucinex Dm (NDC 17856-0056). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - purpose, uses, otc - do not use, otc - ask doctor, otc - when using, otc - stop use, otc - pregnancy or breast feeding, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
| Active ingredients (in each extended-release bi-layer tablet) | Purposes |
| Dextromethorphan HBr 30 mg | Cough suppressant |
| Guaifenesin 600 mg | Expectorant |
Do not use
Ask a doctor before use if you have
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
carbomer homopolymer type B; D&C yellow #10 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
1-866-MUCINEX (1-866-682-4639) You may also report side effects to this phone number.
NDC 17856-0056-1
Mucinex DM
600 mg guaifenesin & 30 mg dextromethorphan HBr
extended-release bi-layer tablets
EXPECTORANT & COUGH SUPPRESSANT
12
HOUR
✓
Controls Cough
✓
Thins and Loosens Mucus
✓
Immediate and Extended Release
20
EXTENDED-RELEASE
BI-LAYER TABLETS
Distributed by:
Atlantic Biologicals
Miami, Fl 33179
* Please review the disclaimer below.